Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings
暂无分享，去创建一个
S. Matsuo | K. Nakao | S. Eguchi | N. Kinoshita | H. Yatsuhashi | M. Hidaka | H. Miyaaki | Masafumi Haraguchi | S. Miuma | R. Sasaki | Masanori Fukushima | Yasuhide Motoyoshi | Masaya Shigeno | Toshihisa Matsuzaki | Y. Kugiyama | Satsuki Hashimoto | K. Tajima | Kazuo Ooba | Yuki Kugiyama